View : 111 Download: 0

A framework for nationwide COVID-19 vaccine safety research in the Republic of Korea: The COVID-19 Vaccine Safety Research Committee

Title
A framework for nationwide COVID-19 vaccine safety research in the Republic of Korea: The COVID-19 Vaccine Safety Research Committee
Authors
Dong-HyunShinHyoung-ShikHanHee ChulLeeJong-KooWooJun HeeByung-JooChoiNam-KyongJeongNa-YoungParkHyesookOhSanghoonJungSeung EunKim
Ewha Authors
박혜숙최남경
SCOPUS Author ID
박혜숙scopusscopus; 최남경scopus
Issue Date
2023
Journal Title
Osong Public Health and Research Perspectives
ISSN
2210-9099JCR Link
Citation
Osong Public Health and Research Perspectives vol. 14, no. 1, pp. 5 - 14
Keywords
CommitteeCOVID-19ResearchSafetyVaccines
Publisher
Korea Centers for Disease Control and Prevention
Indexed
SCOPUS; KCI scopus
Document Type
Article
Abstract
With the introduction of coronavirus disease 2019 (COVID-19) vaccines, the Korea Disease Control and Prevention Agency (KDCA) commissioned the National Academy of Medicine of Korea to gather experts to independently assess post-vaccination adverse events. Accordingly, the COVID-19 Vaccine Safety Research Committee (CoVaSC) was launched in November 2021 to perform safety studies and establish evidence for policy guidance. The CoVaSC established 3 committees for epidemiology, clinical research, and communication. The CoVaSC mainly utilizes pseudonymized data linking KDCA’s COVID-19 vaccination data and the National Health Insurance Service’s claims data. The CoVaSC’s 5-step research process involves defining the target diseases and organizing ad-hoc committees, developing research protocols, performing analyses, assessing causal relationships, and announcing research findings and utilizing them to guide compensation policies. As of 2022, the CoVaSC completed this research process for 15 adverse events. The CoVaSC launched the COVID-19 Vaccine Safety Research Center in September 2022 and has been reorganized into 4 divisions to promote research including international collaborative studies, long-/short-term follow-up studies, and education programs. Through these enhancements, the CoVaSC will continue to swiftly provide scientific evidence for COVID-19 vaccine research and compensation and may serve as a model for preparing for future epidemics of new diseases. © 2023 Korea Disease Control and Prevention Agency.
DOI
10.24171/j.phrp.2023.0026
Appears in Collections:
의과대학 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

BROWSE